Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
99,530,970
-
Share change
-
-1,735,204
-
Total reported value
-
$509,505,477
-
Put/Call ratio
-
118%
-
Price per share
-
$5.12
-
Number of holders
-
153
-
Value change
-
-$13,562,876
-
Number of buys
-
75
-
Number of sells
-
72
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2021
As of 30 Jun 2021 Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) had 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 99,530,970 shares of stock of the company.
Largest 10 holders included Fosun International Ltd, TPG Group Holdings (SBS) Advisors, Inc., VANGUARD GROUP INC, BlackRock Inc., Eversept Partners, LP, Neuberger Berman Group LLC, STATE STREET CORP, Nuveen Asset Management, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and VICTORY CAPITAL MANAGEMENT INC.
This table shows 153 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.